Clinical, Laboratory, and Imaging Features of 148 Patients with COVID-19 in Bushehr: A Report from the South of Iran - Keshavarz, Mohsen; Tavakoli, Ahmad; Zanganeh, Sareh; Mousavi, Mohammad Javad; Vahdat, Katayoun; Mahmudpour, Mehdi; Nabipour, Iraj; Darabi, Amir Hossein; Keshmiri, Saeid (medRxiv, 2020)
Aim To investigate clinical characteristics, laboratory findings, and imaging features of patients confirmed with COVID-19 in Bushehr, a southern province of Iran.Method During April 29th to May 30th 2020, a total of 148 patients confirmed with COVID-19 infection were admitted to three hospitals in Bushehr province, assigned by the Iranian Ministry of Health.Results The most common coexisting disease was type 2 diabetes. Levels of ESR, CRP, LDH, and AST among inpatients were higher than the outpatients (P<0.05). There were significant differences in the levels of creatinine and BUN between elderly and non-elderly patients (P<0.05).Conclusion Patients with comorbidities and elderly patients are at increased risk of severe progression of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was financially supported by a grant (Grant No. 1572) from the Bushehr University of Medical Sciences.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Ethics Committee of Bushehr University of Medical Sciences (ethic code number: IR.BPUMS.REC.1399.026), and written informed consent was obtained from each participant before enrollment.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this article